Pulmonary
  • Asthma
  • COPD
  • Pulmonary
amPulmonary Insights
amPulmonary Insights
amPulmonary enewsletter is the hub of news and cutting-edge information for pulmonary clinicians, researchers, and medical professionals interested in the latest developments.
Topics
  • Asthma
  • COPD
  • Pulmonary
Resources
  • Subscribe
  • About Us
  • Contact Us
  • Sign In
  • Sign In
  • Asthma
  • COPD
  • Pulmonary
  • Subscribe

Site Map

  1. 2026
  2. September
  3. 17
Inpatient PAH therapy transition deemed safe
FDA approves study of inhaled stem cell therapy for COPD
Childhood pollution exposure linked to COPD
Experimental bacterial extract fails to prevent pediatric wheezing or asthma
Tiotropium safe for preschool asthma but not more effective
Page 1 of 1
Pulmonary
Newsletter for Professionals
amPulmonary enewsletter is the hub of news and cutting-edge information for pulmonary clinicians, researchers, and medical professionals interested in the latest developments.
Topics
  • Asthma
  • COPD
  • Pulmonary
  1. Privacy Policy
  2. About Us
  3. Terms & Conditions
  4. Contact Us
  5. Site Map
© 2026 Ascend Integrated Media. All rights reserved.